Logo-jnp
J Nephropathol. 2020;9(1): e08. doi: 10.15171/jnp.2020.08

Original Article

Comparison of clinical outcome of induction immunosuppressive therapy with thymoglobulin and standard therapy in kidney transplantation; a randomized double-blind clinical trial

Heshmatollah Shahbazian 1 ORCID, Ali Ghorbani 1, Fatemeh Hayati 1, Seyed Seifollah Beladi Mousavi 1,2 ORCID, Leila Sabetnia 1 * ORCID, Shahla Ahmadi Halili 1, Shokouh Shayanpour 1 ORCID, Isa Rezaee 1

Cited by CrossRef: 2

1- Data A, Gadekar K, Mogal V, More A, Kulkarni S. Study of Noninduction Immunosuppression in Intermediate-Risk Living Donor Kidney Transplantation in Rural Population of India - A Retrospective Observational Study. 2022;16(1):113 [Crossref]
2- Montero N, Rodrigo E, Crespo M, Cruzado J, Gutierrez-Dalmau A, Mazuecos A, Sancho A, Belmar L, Calatayud E, Mora P, Oliveras L, Solà E, Villanego F, Pascual J. The use of lymphocyte-depleting antibodies in specific populations of kidney transplant recipients: A systematic review and meta-analysis. Transplantation Reviews. 2023;37(4):100795 [Crossref]